Monoclonal antibody therapeutics and apoptosis
نویسندگان
چکیده
منابع مشابه
Monoclonal antibody therapeutics with up to five specificities
The recognition that few human diseases are thoroughly addressed by mono-specific, monoclonal antibodies (mAbs) continues to drive the development of antibody therapeutics with additional specificities and enhanced activity. Historically, efforts to engineer additional antigen recognition into molecules have relied predominantly on the reformatting of immunoglobulin domains. In this report we d...
متن کاملAntibody Engineering and Therapeutics
note: The views expressed herein are those of the authors and do not necessarily reflect the views of their respective employers. Speakers who wrote a summary of their own presentation are listed in the header for the relevant session. The majority of the other summaries in this report were based on PDFs of the presentations provided by speakers or on post-meeting input from the speakers. The a...
متن کاملAntibody engineering and therapeutics conference
Half-day pre-conference workshops on three-dimensional (3D) structure antibody modeling and on identifying clonal lineages from next-generation data sets of expressed VH gene sequences will be held on Sunday December 8, 2013. The modeling workshop will be moderated by Juan Carlos Almagro (Pfizer, Inc and Gary L Gilliland (Janssen R&D, Inc. With the success of antibody-based therapeutics, protei...
متن کاملCONCISE REVIEWS OF PEDIATRIC INFECTIOUS DISEASES Monoclonal Antibody Therapeutics and Risk for Infection
The discovery of a method to produce continuous mouse cell lines synthesizing antibodies of predetermined specificity so revolutionized diagnostics and therapeutics that the scientists responsible were awarded a Nobel Prize only 9 years after their publication. The therapeutic application of monoclonal antibodies (MAbs) as “magic bullets” began with the approval of a murine antibody, muromonab ...
متن کاملAntibody Therapeutics in Oncology
One of the newer classes of targeted cancer therapeutics is monoclonal antibodies. Monoclonal antibody therapeutics are a successful and rapidly expanding drug class due to their high specificity, activity, favourable pharmacokinetics, and standardized manufacturing processes. Antibodies are capable of recruiting the immune system to attack cancer cells through complement-dependent cytotoxicity...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Oncogene
سال: 2003
ISSN: 0950-9232,1476-5594
DOI: 10.1038/sj.onc.1207104